Cargando…
Therapeutic efficacy of rscAAVrh74.miniCMV.LIPA gene therapy in a mouse model of lysosomal acid lipase deficiency
Lysosomal acid lipase deficiency (LAL-D) presents as one of two rare autosomal recessive diseases: Wolman disease (WD), a severe disorder presenting in infancy characterized by absent or very low LAL activity, and cholesteryl ester storage disease (CESD), a less severe, later onset disease form. Rec...
Autores principales: | Lam, Patricia, Ashbrook, Anna, Zygmunt, Deborah A., Yan, Cong, Du, Hong, Martin, Paul T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403906/ https://www.ncbi.nlm.nih.gov/pubmed/36092360 http://dx.doi.org/10.1016/j.omtm.2022.08.001 |
Ejemplares similares
-
rAAVrh74.MCK.GALGT2 Demonstrates Safety and Widespread Muscle Glycosylation after Intravenous Delivery in C57BL/6J Mice
por: Zygmunt, Deborah A., et al.
Publicado: (2019) -
A Novel Homozygous LIPA Mutation in a Korean Child with Lysosomal Acid Lipase Deficiency
por: Kim, Kwang Yeon, et al.
Publicado: (2017) -
Coronary Artery Disease–Associated LIPA Coding Variant rs1051338 Reduces Lysosomal Acid Lipase Levels and Activity in Lysosomes
por: Morris, Gavin E., et al.
Publicado: (2017) -
Large‐scale functional LIPA variant characterization to improve birth prevalence estimates of lysosomal acid lipase deficiency
por: del Angel, Guillermo, et al.
Publicado: (2019) -
Inhibition of Autolysis by Lipase LipA in Streptococcus pneumoniae Sepsis
por: Kim, Gyu-Lee, et al.
Publicado: (2017)